These founders and investors want the longevity industry to cater to women—whatever their budget
Data from the National Center for Health Statistics shows that women in the United States currently live an average of 5.8 ...
Accenture CEO’s Cancer Diagnosis Gives Insight Into How Execs Divulge Illness
Accenture CEO Julie Sweet was praised this week for her openness regarding a breast cancer diagnosis, which also gave rare ...
Accenture CEO Julie Sweet’s cancer diagnosis shows how execs should share life-altering health events
Good morning. Accenture CEO Julie Sweet announced yesterday that her breast cancer has come back, noting in a memo to staff ...
Meet CEO of one of world's biggest IT firms, who will undergo treatment for breast cancer
Julie Sweet, Chief Executive Officer of Accenture has recently been diagnosed with early-stage breast cancer and will undergo ...
Accenture CEO diagnosed with breast cancer, to undergo surgery next week
However, the CEO will continue to look after the day-to-day operations of the IT services and consulting firm during the ...
Accenture CEO Julie Sweet diagnosed with cancer, to undergo surgery next week
Accenture CEO Julie Sweet has been diagnosed with early-stage breast cancer. With an excellent prognosis and a curable ...
Accenture CEO Julie Sweet diagnosed with early-stage breast cancer, treatment likely to last 12-16 weeks
Nonetheless, the CEO of the world’s largest IT company will lead its day-to-day operations throughout the process.
ARN8d
US tech company DE&I rollbacks on ‘collision course’ with Aussie govt contracts
The global nature of US technology companies means that changes in their diversity policies to meet executive and legal ...
Accenture CEO Julie Sweet shares health update
Accenture plc (NYSE:ACN), a $243 billion market cap technology consulting giant, disclosed an update on the health of Julie Sweet, the company's Chair and Chief Executive Officer. In a message to all ...